Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine for RPL in Women with Subclinical Hypothyroidism
NCT03106935Phase 1Unknown
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Jul 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of levothyroxine sodium in recurrent pregnancy loss (RPL) and hypothyroidism, sponsored by The Second Affiliated Hospital of Soochow University. Primary endpoints: Gestational week at delivery at 28 weeks, Newborn birth weight and 1 more. Status: unknown.
02
Drugs
levothyroxine sodium
03
Conditions
recurrent pregnancy loss (RPL)hypothyroidism
Beyond the preview
Go deeper on NCT03106935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03106935.